Adjuvant treatment in biliary tract cancer (original) (raw)

Adjuvant treatment in biliary tract cancer: To treat or not to treat?

World Journal of Gastroenterology, 2012

A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer

International Journal of Clinical Oncology, 2013

Prognostic Factors and Adjuvant Treatments for Surgically Treated Cancers of the Biliary Tract: A Multicentre Study of the Anatolian Society of Medical Oncology (ASMO)

Veli Berk

Asian Pacific journal of cancer prevention : APJCP, 2014

View PDFchevron_right

Factors influencing survival outcome for radiotherapy for biliary tract cancer: A multicenter retrospective study

Fumiaki Isohashi, Yasumasa Nishimura

Radiotherapy and Oncology, 2014

View PDFchevron_right

Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer

J. Skipworth

Alimentary Pharmacology & Therapeutics, 2011

View PDFchevron_right

Biliary Tract Cancer: Current Medical Treatment Strategies

Ester Oneda, Alberto Zaniboni

View PDFchevron_right

Treatment of borderline cases for curative resection of biliary tract cancer

Yutaka Takeda, Masahiro Tanemura

Journal of Surgical Oncology, 2011

View PDFchevron_right

Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis

Gianluca Tomasello

HPB

View PDFchevron_right

Gemcitabine plus cisplatin versus chemoradiotherapy in locally advanced biliary tract cancer: Fédération Francophone de Cancérologie Digestive 9902 phase II randomised study

Côme Lepage

European journal of cancer (Oxford, England : 1990), 2014

View PDFchevron_right

A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in curatively resected patients with biliary tract cancer: adjusting the dose of adjuvant chemotherapy according to the surgical procedures

Go Wakabayashi

Cancer Chemotherapy and Pharmacology, 2012

View PDFchevron_right

Radiation therapy for biliary tract tumors: the joint experience of three centers*

binnaz sarper

TURKISH JOURNAL OF MEDICAL SCIENCES, 2017

View PDFchevron_right

Radiotherapy or Chemoradiation in Unresectable Biliary Cancer: A Retrospective Study

Giovanni Brandi

Anticancer Research, 2019

View PDFchevron_right

Chemotherapy with Gemcitabine in Advanced Biliary Tract Carcinoma

Raquel Gerson

Reviews on Recent Clinical Trials, 2008

View PDFchevron_right

Comparison of 4-Weekly vs 3-Weekly Gemcitabine as Adjuvant Chemotherapy Following Curative Resection for Biliary Tract Cancer: A Prospective Randomized Controlled Trial

Junzo Shimizu

Journal of Cancer Therapy, 2011

View PDFchevron_right

Clinicopathological Features of Surgically-resected Biliary Tract Cancer Following Chemo-radiation Therapy

Terumasa Yamada

Anticancer research, 2016

View PDFchevron_right

Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004)

Masanori Toyoda

Cancer Chemotherapy and Pharmacology, 2014

View PDFchevron_right

Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy

Marine Jary, Stefano Kim

BMC Gastroenterology, 2014

View PDFchevron_right

Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy

Nobuo Toda

Cancer Chemotherapy and Pharmacology, 2011

View PDFchevron_right

Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. PART II: Multidisciplinary management

Md. Arif Shaikh

Journal of Surgical Oncology, 2012

View PDFchevron_right

Radiotherapy and Chemotherapy as Therapeutic Strategies in Extrahepatic Biliary Duct Carcinoma

Cynthia L Eccles DPHIL

Strahlentherapie und Onkologie

View PDFchevron_right

Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas

G. Van Hazel

Cancer Chemotherapy and Pharmacology, 2010

View PDFchevron_right

A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected biliary tract cancer in a multi-institutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01)

Takuya Minagawa

Research Square (Research Square), 2020

View PDFchevron_right

Guidelines for chemotherapy of biliary tract and ampullary carcinomas

Koichi Hirata, Masahiro Yoshida, Fumihiko Miura

Journal of Hepato-Biliary-Pancreatic Surgery, 2008

View PDFchevron_right

Phase II Trial of Cisplatin , Interferon-2 b , Doxorubicin , and 5-Fluorouracil for Biliary Tract Cancer 1

I. Schnirer

2001

View PDFchevron_right

A review of systemic therapy in biliary tract carcinoma

Ulrich-frank Pape

Journal of Gastrointestinal Oncology

View PDFchevron_right

Patients with recurrent biliary tract cancer have a better prognosis than those with unresectable disease: retrospective analysis of a multi-institutional experience with patients of advanced biliary tract cancer who received palliative chemotherapy

Yutaka Takeda

Journal of hepato-biliary-pancreatic sciences, 2014

View PDFchevron_right

Updated Management of Malignant Biliary Tract Tumors: An Illustrative Review

Carlo Catalano

Journal of Vascular and Interventional Radiology, 2016

View PDFchevron_right

Chemoradiotherapy for patients with locally advanced or unresectable extra-hepatic biliary cancer

Shilpa Sannapaneni

Journal of Gastrointestinal Oncology, 2020

View PDFchevron_right

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

Paul Ross

The Lancet Oncology

View PDFchevron_right

Adjuvant treatment in biliary tract cancer (original) (raw)

Related papers